当前位置:首页 - 行情中心 - 前沿生物-U(688221) - 财务分析 - 现金流量表

前沿生物-U

(688221)

  

流通市值:64.88亿  总市值:64.88亿
流通股本:3.75亿   总股本:3.75亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金380,302,958.52327,999,458.11112,281,305.4682,793,398.91
  收到其他与经营活动有关的现金1,591,393.5879,609.887,410,314.696,197,729.92
  经营活动现金流入小计381,894,352.02328,879,067.99119,691,620.1588,991,128.83
  购买商品、接受劳务支付的现金17,530,594.0110,273,270.2147,258,975.425,612,230.27
  支付给职工以及为职工支付的现金60,009,993.3335,522,873.18105,886,150.7780,771,678.1
  支付的各项税费1,860,156.98893,005.93,215,140.462,381,331.42
  支付其他与经营活动有关的现金121,604,642.0864,310,129.44189,919,656.29132,015,477.64
  经营活动现金流出小计201,005,386.4110,999,278.73346,279,922.92240,780,717.43
  经营活动产生的现金流量净额180,888,965.62217,879,789.26-226,588,302.77-151,789,588.6
二、投资活动产生的现金流量:
  取得投资收益收到的现金6,975,504.264,040,837.2712,222,334.5110,209,145.79
  处置固定资产、无形资产和其他长期资产收回的现金净额1,391,409.430034,00028,000
  处置子公司及其他营业单位收到的现金净额--27,473,375.3415,128,712.33
  收到的其他与投资活动有关的现金1,341,923,000647,700,0002,973,387,512.332,453,828,100
  投资活动现金流入小计1,350,289,913.66651,741,137.273,013,117,222.182,479,193,958.12
  购建固定资产、无形资产和其他长期资产支付的现金3,322,689.222,214,541.0529,864,170.7826,075,665.31
  支付其他与投资活动有关的现金1,310,522,199.21910,066,4002,810,570,0002,397,670,000
  投资活动现金流出小计1,313,844,888.43912,280,941.052,840,434,170.782,423,745,665.31
  投资活动产生的现金流量净额36,445,025.23-260,539,803.78172,683,051.455,448,292.81
三、筹资活动产生的现金流量:
  取得借款收到的现金242,258,756.4142,258,756.4361,850,023.44289,559,879.25
  筹资活动现金流入小计242,258,756.4142,258,756.4361,850,023.44289,559,879.25
  偿还债务支付的现金228,641,80078,017,800362,623,796.37323,472,535.62
  分配股利、利润或偿付利息支付的现金5,657,361.251,973,748.418,193,704.96,303,490.88
  支付其他与筹资活动有关的现金2,468,1242,289,91215,455,43315,000,000
  筹资活动现金流出小计236,767,285.2582,281,460.41386,272,934.27344,776,026.5
  筹资活动产生的现金流量净额5,491,471.1559,977,295.99-24,422,910.83-55,216,147.25
四、汇率变动对现金及现金等价物的影响57,156.55-60,241.86-47,436.25-26,046.19
五、现金及现金等价物净增加额222,882,618.5517,257,039.61-78,375,598.45-151,583,489.23
  加:期初现金及现金等价物余额170,344,359.37170,344,359.37248,719,957.82248,719,957.82
  期末现金及现金等价物余额393,226,977.92187,601,398.98170,344,359.3797,136,468.59
补充资料:
  净利润148,929,627.03--268,053,032.03-
  资产减值准备1,902,431.86-2,866,584.85-
  固定资产和投资性房地产折旧12,967,053.83-20,709,667.09-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧12,926,783.99-20,709,667.09-
    投资性房地产折旧40,269.84---
  无形资产摊销10,706,566.44-21,616,253.3-
  长期待摊费用摊销490,454.36-589,964.8-
  处置固定资产、无形资产和其他长期资产的损失-709,473.65-26,728.07-
  固定资产报废损失1,564.59-1,806.06-
  公允价值变动损失-4,211,440.53-546,697.65-
  财务费用3,984,916.04-8,625,645.13-
  投资损失-7,691,881.72-1,062,974.77-
  存货的减少2,331,544.55--19,113,212.28-
  经营性应收项目的减少9,503,821.11--27,872,292.61-
  经营性应付项目的增加-7,169,437.8-5,831,261.21-
  其他7,993,265.75-3,595,045.86-
  现金的期末余额393,226,977.92-170,344,359.37-
  减:现金的期初余额170,344,359.37-248,719,957.82-
  现金及现金等价物的净增加额222,882,618.55--78,375,598.45-
公告日期2026-08-312026-04-252026-04-252025-10-31
审计意见(境内)标准无保留意见
TOP↑